-
1.发明申请COMPOSITIONS AND METHODS FOR THE CONTROL, PREVENTION AND TREATMENT OF OBESITY AND EATING DISORDERS 失效用于控制，预防和治疗肥胖和发作障碍的组合物和方法公开(公告)号：US20110263491A1
公开(公告)日：2011-10-27
申请号：US12964516
申请日：2010-12-09
摘要： Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet and nutrition are provided. The methods provided generally involve the administration of an Amylin or an Amylin agonist to a subject in order to prevent, treat or control conditions or disorders associated with obesity, diet and nutrition.
摘要翻译： 提供了用于预防，治疗或控制与肥胖，饮食和营养相关的病症或障碍的组合物和方法。 所提供的方法通常包括向受试者施用胰岛淀粉样多肽和胰岛淀粉样多肽激动剂以预防，治疗或控制与肥胖，饮食和营养相关的病症或障碍。
-
2.发明授权Method of modifying food preference comprising administering amylin or amylin agonist 失效改变食物偏好的方法包括给予胰岛淀粉样多肽或胰岛淀粉样多肽激动剂公开(公告)号：US08278267B2
公开(公告)日：2012-10-02
申请号：US12964516
申请日：2010-12-09
摘要： Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet and nutrition are provided. The methods provided generally involve the administration of an Amylin or an Amylin agonist to a subject in order to prevent, treat or control conditions or disorders associated with obesity, diet and nutrition.
摘要翻译： 提供了用于预防，治疗或控制与肥胖，饮食和营养相关的病症或障碍的组合物和方法。 所提供的方法通常包括向受试者施用胰岛淀粉样多肽和胰岛淀粉样多肽激动剂以预防，治疗或控制与肥胖，饮食和营养相关的病症或障碍。
-
公开(公告)号：US07879794B2
公开(公告)日：2011-02-01
申请号：US11910214
申请日：2006-03-31
IPC分类号： A61K38/00
摘要： Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet, and nutrition are provided. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to prevent, treat or controlling conditions or disorders associated with obesity, diet, and nutrition.
摘要翻译： 提供了用于预防，治疗或控制与肥胖，饮食和营养相关的病症或障碍的组合物和方法。 所提供的方法通常包括向受试者施用胰岛淀粉样多肽或胰岛淀粉样多肽激动剂以预防，治疗或控制与肥胖，饮食和营养相关的病症或障碍。
-
4.发明申请COMPOSITIONS AND METHODS FOR THE CONTROL, PREVENTION AND TREATMENT OF OBESITY AND EATING DISORDERS 失效用于控制，预防和治疗肥胖和发作障碍的组合物和方法公开(公告)号：US20090062193A1
公开(公告)日：2009-03-05
申请号：US11910214
申请日：2006-03-31
摘要： Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet, and nutrition are provided. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to prevent, treat or controlling conditions or disorders associated with obesity, diet, and nutrition.
摘要翻译： 提供了用于预防，治疗或控制与肥胖，饮食和营养相关的病症或障碍的组合物和方法。 所提供的方法通常包括向受试者施用胰岛淀粉样多肽或胰岛淀粉样多肽激动剂以预防，治疗或控制与肥胖，饮食和营养相关的病症或障碍。
-
5.发明申请Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders 审中-公开胰岛淀粉样多肽和胰岛淀粉样多肽激动剂治疗精神疾病和疾病公开(公告)号：US20090181890A1
公开(公告)日：2009-07-16
申请号：US12295259
申请日：2006-10-04
CPC分类号： A61K38/22 , A61K31/5513 , A61K45/06 , A61K2300/00
摘要： Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
摘要翻译： 公开了治疗精神疾病和病症的方法和组合物。 提供的方法通常涉及对受试者施用胰岛淀粉样多肽或胰岛淀粉样多肽激动剂以治疗精神疾病和病症，以及与精神疾病和病症相关的病症。
-
6.发明申请Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders 审中-公开胰岛淀粉样多肽和胰岛淀粉样多肽激动剂治疗精神疾病和疾病公开(公告)号：US20100125054A1
公开(公告)日：2010-05-20
申请号：US12641733
申请日：2009-12-18
摘要： Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
摘要翻译： 公开了治疗精神疾病和病症的方法和组合物。 提供的方法通常涉及对受试者施用胰岛淀粉样多肽或胰岛淀粉样多肽激动剂以治疗精神疾病和病症，以及与精神疾病和病症相关的病症。
-
7.发明申请AMYLIN AND AMYLIN AGONISTS FOR TREATING PSYCHIATRIC DISEASES AND DISORDERS 失效用于治疗心理疾病和疾病的AMYLIN和AMYLIN激动剂公开(公告)号：US20110288028A1
公开(公告)日：2011-11-24
申请号：US13112290
申请日：2011-05-20
摘要： Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
摘要翻译： 公开了治疗精神疾病和病症的方法和组合物。 提供的方法通常涉及对受试者施用胰岛淀粉样多肽或胰岛淀粉样多肽激动剂以治疗精神疾病和病症，以及与精神疾病和病症相关的病症。
-
公开(公告)号：US20130035294A1
公开(公告)日：2013-02-07
申请号：US13651130
申请日：2012-10-12
CPC分类号： A61K38/22
摘要： Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an NMX peptide, an FNX peptide, or an NMX receptor agonist, or analogs or derivatives thereof, to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
摘要翻译： 公开了治疗精神疾病和病症的方法和组合物。 所提供的方法通常涉及向受试者施用NMX肽，FNX肽或NMX受体激动剂或其类似物或衍生物，以治疗精神疾病和病症，以及与精神疾病和病症相关的病症。
-
9.发明授权Amylin agonist for treating depression, anxiety disorder and schizophrenia 失效用于治疗抑郁症，焦虑障碍和精神分裂症的胰岛淀粉样多肽激动剂公开(公告)号：US07671023B2
公开(公告)日：2010-03-02
申请号：US11910206
申请日：2006-03-31
摘要： Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
摘要翻译： 公开了治疗精神疾病和病症的方法和组合物。 提供的方法通常涉及对受试者施用胰岛淀粉样多肽或胰岛淀粉样多肽激动剂以治疗精神疾病和病症，以及与精神疾病和病症相关的病症。
-
公开(公告)号：US20130184213A1
公开(公告)日：2013-07-18
申请号：US13777149
申请日：2013-02-26
摘要： Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
-
-
-
-
-
-
-
-
-
搜索结果
35 条记录 (耗时 0.038 秒)